Multimodal Prehabilitation in Radioactive Iodine-Refractory Differentiated Thyroid Cancer Treated with Lenvatinib

1. Abstract

1.1. Purpose: This study describes our clinical experience with lenvatinib for the treatment of radioactive iodine refractory Differentiated Thyroid Cancer (RR-DTC) using a multimodal patient- centered prehabilitation multidisciplinary approach assessing its effectiveness and patient outcomes.